Treatment of patients with metastatic melanoma (AJCC stage IV or III unresectable) with the PDE-inhibitor Tadalafil: A Pilot Trial for "Proof of Principle".
Phase of Trial: Phase II
Latest Information Update: 30 Jun 2017
At a glance
- Drugs Tadalafil (Primary)
- Indications Malignant melanoma
- Focus Pharmacodynamics
- Acronyms TaMe
- 07 Nov 2015 Status changed from recruiting to completed, as reported by European clinical Trials Database.
- 18 Feb 2012 New trial record